Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Amortization of Deferred Charges (2019 - 2025)

Historic Amortization of Deferred Charges for Cue Biopharma (CUE) over the last 6 years, with Q3 2025 value amounting to $9000.0.

  • Cue Biopharma's Amortization of Deferred Charges changed 0.0% to $9000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $36000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $37000.0 for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Cue Biopharma's Amortization of Deferred Charges is $9000.0, which was down 0.0% from $9000.0 recorded in Q2 2025.
  • In the past 5 years, Cue Biopharma's Amortization of Deferred Charges ranged from a high of $10000.0 in Q4 2022 and a low of $3000.0 during Q1 2022
  • Over the past 4 years, Cue Biopharma's median Amortization of Deferred Charges value was $9000.0 (recorded in 2022), while the average stood at $8666.7.
  • Examining YoY changes over the last 5 years, Cue Biopharma's Amortization of Deferred Charges showed a top increase of 20000.0% in 2023 and a maximum decrease of 1000.0% in 2023.
  • Quarter analysis of 4 years shows Cue Biopharma's Amortization of Deferred Charges stood at $10000.0 in 2022, then dropped by 10.0% to $9000.0 in 2023, then changed by 0.0% to $9000.0 in 2024, then changed by 0.0% to $9000.0 in 2025.
  • Its Amortization of Deferred Charges stands at $9000.0 for Q3 2025, versus $9000.0 for Q2 2025 and $9000.0 for Q1 2025.